To understand the efficacy of Daphne indica for tobacco abuse, using Fagerstrom Test for Nicotine Dependence.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Mean change in FTND score from baseline.
研究概览
简要总结
As we know that tobacco use remains widespread in India owing to the social, cultural and psychological factors which leads to high prevalence of tobacco abuse among the citizens (especially the youth). This study is being conducted to test the efficacy of Daphne indica 30 for tobacco abuse. The main goal is to see if it reduces the craving effects for tobacco without any harmful side effects as in modern system of medicine, and also if it can manage the other withdrawal symptoms like anxiety, confusion, dizziness, irritability, loss of appetite etc.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 15.00 Year(s) 至 50.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Patients within the age group of 15-50 years, both male and female.
- •2.Current tobacco users: Individuals who currently use tobacco products in any form (e.g., chewing tobacco, cigarettes, smokeless tobacco, e-cigarettes, snuff) regularly.
- •3.Duration of tobacco use: Participants who have used tobacco for a minimum duration (e.g., at least 6 months or 1 year) to ensure a certain level of addiction or regular usage.
- •4.Motivation to quit: Individuals actively seeking help to quit or reduce tobacco use.
- •5.Willingness to participate: Participants must be willing to give informed consent and comply with the study protocol.
排除标准
- •1.Patients younger than 15 years or older than 50 years.
- •2.Non smokers: Participants who have never smoked or used any tobacco products.
- •3.Patients with serious health conditions that could confound the results or make participation unsafe (e.g., severe cardiovascular disease, lung cancer, or other terminal illnesses).
- •4.Pregnant or breastfeeding women: Tobacco use in pregnancy is a critical risk factor, so pregnant women may be excluded to focus on other aspects of tobacco abuse.
- •History of substance abuse: Participants with a history of drug or alcohol dependence (other than tobacco) may be excluded to isolate the effects of tobacco use.
- •6.Individuals not willing to participate: Those who are unwilling or unable to follow the study protocol, including adherence to follow-up visits.
结局指标
主要结局
Mean change in FTND score from baseline.
时间窗: Baseline, 3rd month, 6th month, 9th month
次要结局
- To assess the improvement in withdrawal symptoms such as anxiety, confusion, dizziness, irritability etc.(Baseline, 3rd month, 6th month, 9th month)
研究者
Dr Priyanka Hasani
Anand Homoeopathic Medical College and Research Institute
